| Year |
Citation |
Score |
| 2024 |
Hastert TA, McDougall JA, Robinson JRM, Palakshappa D, Seaton R, Ruterbusch JJ, Beebe-Dimmer JL, Schwartz AG. Age at diagnosis and social risks among Black cancer survivors: Results from the Detroit Research on Cancer Survivors cohort. Cancer. PMID 38280205 DOI: 10.1002/cncr.35212 |
0.375 |
|
| 2023 |
Robinson JRM, Hastert TA, Beebe-Dimmer JL, Schwartz AG, Ruterbusch JJ, Pandolfi SS, Rundle AG. Housing instability and psychological distress in African American cancer survivors: findings from the Detroit Research on Cancer Survivors study. Journal of Cancer Survivorship : Research and Practice. PMID 37798594 DOI: 10.1007/s11764-023-01471-5 |
0.393 |
|
| 2023 |
Raychaudhuri S, Kyko JM, Ruterbusch JJ, Pandolfi SS, Beebe-Dimmer JL, Schwartz AG, Simon MS. The impact of preexisting comorbidities on receipt of cancer therapy among women with Stage I-III breast cancer in the Detroit Research on Cancer Survivors cohort. Cancer Medicine. PMID 37563982 DOI: 10.1002/cam4.6456 |
0.345 |
|
| 2022 |
Wei J, Beebe-Dimmer J, Shi Z, Sample C, Yan G, Rifkin AS, Sadeghpour A, Gielzak M, Choi S, Moon D, Zheng SL, Helfand BT, Walsh PC, Xu J, Cooney KA, et al. Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry. The Prostate. PMID 36567534 DOI: 10.1002/pros.24477 |
0.337 |
|
| 2022 |
Trendowski MR, Sample C, Baird T, Sadeghpour A, Moon D, Ruterbusch JJ, Beebe-Dimmer JL, Cooney KA. Germline Variants in DNA Damage Repair Genes and Among Black Patients With Early-Onset Prostate Cancer. Jco Precision Oncology. 6: e2200460. PMID 36446039 DOI: 10.1200/PO.22.00460 |
0.368 |
|
| 2022 |
Trendowski MR, Kyko JM, Lusk CM, Ruterbusch JJ, Hastert TA, Harper FWK, Thompson H, Beebe-Dimmer JL, Schwartz AG. Evaluation of health behaviors and overall quality of life in younger adult African American cancer survivors. Cancer Medicine. PMID 35655423 DOI: 10.1002/cam4.4855 |
0.35 |
|
| 2021 |
Beebe-Dimmer JL, Lusk CM, Ruterbusch JJ, Baird TE, Pandolfi SS, Wenzlaff AS, Hastert TA, Harper FWK, Thompson HS, Schwartz AG. The impact of the COVID-19 pandemic on African American cancer survivors. Cancer. PMID 34706056 DOI: 10.1002/cncr.33987 |
0.354 |
|
| 2021 |
Trendowski MR, Lusk CM, Ruterbusch JJ, Seaton R, Simon MS, Greenwald MK, Harper FWK, Beebe-Dimmer JL, Schwartz AG. Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes. Cancer Medicine. 10: 8151-8161. PMID 34687150 DOI: 10.1002/cam4.4328 |
0.366 |
|
| 2021 |
Robinson JRM, Beebe-Dimmer JL, Schwartz AG, Ruterbusch JJ, Baird TE, Pandolfi SS, Hastert TA, Quinn JW, Rundle AG. Neighborhood walkability and body mass index in African American cancer survivors: The Detroit Research on Cancer Survivors study. Cancer. PMID 34406654 DOI: 10.1002/cncr.33869 |
0.39 |
|
| 2020 |
Hastert TA, McDougall JA, Strayhorn SM, Nair M, Beebe-Dimmer JL, Schwartz AG. Social needs and health-related quality of life among African American cancer survivors: Results from the Detroit Research on Cancer Survivors study. Cancer. PMID 33225460 DOI: 10.1002/cncr.33286 |
0.304 |
|
| 2020 |
Hastert TA, Kirchhoff AC, Banegas MP, Morales JF, Nair M, Beebe-Dimmer JL, Pandolfi SS, Baird TE, Schwartz AG. Work changes and individual, cancer-related, and work-related predictors of decreased work participation among African American cancer survivors. Cancer Medicine. PMID 33159501 DOI: 10.1002/cam4.3512 |
0.376 |
|
| 2020 |
Purrington KS, Raychaudhuri S, Simon MS, Clark J, Ratliff V, Dyson G, Craig DB, Boerner JL, Beebe-Dimmer JL, Schwartz AG. Heritable susceptibility to breast cancer among African American women in the Detroit Research on Cancer Survivors Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32868316 DOI: 10.1158/1055-9965.Epi-20-0564 |
0.333 |
|
| 2020 |
Malburg CM, Fucinari J, Ruterbusch JJ, Ledgerwood DM, Beebe-Dimmer JL, Schwartz AG, Cote ML. Continued smoking in African American cancer survivors: The Detroit Research on Cancer Survivors Cohort. Cancer Medicine. PMID 32822118 DOI: 10.1002/Cam4.3368 |
0.363 |
|
| 2020 |
Purrington KS, Schwartz AG, Ruterbusch JJ, Manning MA, Nair M, Wenzlaff AS, Pandolfi SS, Simon MS, Beebe-Dimmer J. Patterns of cancer family history and genetic counseling eligibility among African Americans with breast, prostate, lung, and colorectal cancers: A Detroit Research on Cancer Survivors cohort study. Cancer. PMID 32749684 DOI: 10.1002/cncr.33126 |
0.415 |
|
| 2020 |
Beebe-Dimmer JL, Kapron AL, Fraser AM, Smith KR, Cooney KA. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902808. PMID 32208047 DOI: 10.1200/Jco.19.02808 |
0.43 |
|
| 2020 |
Beebe-Dimmer JL, Ruterbusch JJ, Harper FWK, Baird TM, Finlay DG, Rundle AG, Pandolfi SS, Hastert TA, Schwartz KL, Bepler G, Simon MS, Mantey J, Abrams J, Albrecht TL, Schwartz AG. Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study. Cancer. PMID 32090322 DOI: 10.1002/cncr.32725 |
0.371 |
|
| 2020 |
Senft N, Abrams J, Katz A, Barnes C, Charbonneau DH, Beebe-Dimmer JL, Zhang K, Eaton T, Heath E, Thompson HS. eHealth Activity among African American and White Cancer Survivors: A New Application of Theory. Health Communication. 35: 350-355. PMID 32013612 DOI: 10.1080/10410236.2018.1563031 |
0.315 |
|
| 2020 |
Hovsepyan G, Lehman A, Thomson CA, Iyengar NM, Beebe-Dimmer JL, Barac A, Shadyab AH, Brasky T, Saquib N, Wild R, Desai P, Caan BJ, Simon MS. Lipid levels and survival after obesity-related cancer in the Women’s Health Initiative CVD biomarker cohort. Journal of Clinical Oncology. 38: e13618-e13618. DOI: 10.1200/Jco.2020.38.15_Suppl.E13618 |
0.313 |
|
| 2019 |
Beebe-Dimmer JL, Ruterbusch JJ, Cooney KA, Bolton A, Schwartz K, Schwartz AG, Heath E. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation. Cancer Medicine. PMID 31094098 DOI: 10.1002/Cam4.2092 |
0.35 |
|
| 2019 |
Beebe-Dimmer JL, Cooney KA. Mitochondrial alterations may underlie race-specific differences in cancer risk and outcome. The Journal of Clinical Investigation. 130. PMID 31063989 DOI: 10.1172/Jci128707 |
0.302 |
|
| 2019 |
Holowatyj AN, Heath EI, Pappas LM, Ruterbusch JJ, Gorski DH, Triest JA, Park HK, Beebe-Dimmer JL, Schwartz AG, Cote ML, Schwartz KL. The Epidemiology of Cancer Among Homeless Adults in Metropolitan Detroit. Jnci Cancer Spectrum. 3: pkz006. PMID 30944890 DOI: 10.1093/Jncics/Pkz006 |
0.389 |
|
| 2019 |
Arthur RS, Kabat GC, Kim MY, Wild RA, Shadyab AH, Wactawski-Wende J, Ho GYF, Reeves KW, Kuller LH, Luo J, Beebe-Dimmer J, Simon MS, Strickler H, Wassertheil-Smoller S, Rohan TE. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study. Cancer Causes & Control : Ccc. PMID 30788634 DOI: 10.1007/S10552-019-01139-5 |
0.32 |
|
| 2019 |
Griffin K, Csizmadi I, Howard LE, Pomann GM, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Terris MK, Beebe-Dimmer J, Freedland SJ. First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH. Cancer Causes & Control : Ccc. PMID 30701374 DOI: 10.1007/s10552-019-1133-5 |
0.336 |
|
| 2019 |
Van Dyke AL, Shiels MS, Jones GS, Pfeiffer RM, Petrick JL, Beebe-Dimmer JL, Koshiol J. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013. Cancer. PMID 30645774 DOI: 10.1002/Cncr.31942 |
0.461 |
|
| 2018 |
Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK, Simon MS, Abrams J, Schwartz KL, Schwartz AG. The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30482875 DOI: 10.1158/1055-9965.EPI-18-0123 |
0.381 |
|
| 2018 |
Dyson G, Farran B, Bolton S, Craig DB, Dombkowski A, Beebe-Dimmer JL, Powell IJ, Podgorski I, Heilbrun LK, Bock CH. The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer. American Journal of Cancer Research. 8: 2088-2095. PMID 30416858 |
0.304 |
|
| 2018 |
Cooney KA, Beebe-Dimmer JL. Finding a Needle in the Haystack: The Search for Germline Variants Associated with Prostate Cancer Clinical Outcomes. European Urology. PMID 30029823 DOI: 10.1016/J.Eururo.2018.07.001 |
0.304 |
|
| 2018 |
Levin RA, Lund ME, Truong Q, Wu A, Shore ND, Saltzstein DR, Concepcion RS, Paivanas TA, van Breda A, Beebe-Dimmer J, Ruterbusch JJ, Wissmueller S, Campbell DH, Walsh BJ. Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker. Oncotarget. 9: 22359-22367. PMID 29854284 DOI: 10.18632/oncotarget.25009 |
0.317 |
|
| 2018 |
Campbell DH, Lund ME, Nocon AL, Cozzi PJ, Frydenberg M, De Souza P, Schiller B, Beebe-Dimmer JL, Ruterbusch JJ, Walsh BJ. Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. Plos One. 13: e0196017. PMID 29672570 DOI: 10.1371/journal.pone.0196017 |
0.322 |
|
| 2018 |
Beebe-Dimmer JL, Zuhlke KA, Johnson AM, Liesman D, Cooney KA. Rare germline mutations in African American men diagnosed with early-onset prostate cancer. The Prostate. PMID 29356034 DOI: 10.1002/Pros.23464 |
0.367 |
|
| 2018 |
Hastert TA, Harper FWK, Beebe-Dimmer JL, Baird T, Schwartz AG. Material and behavioral financial hardship as predictors of health-related quality of life in a diverse cohort of cancer survivors. Journal of Clinical Oncology. 36: 145-145. DOI: 10.1200/JCO.2018.36.7_suppl.145 |
0.366 |
|
| 2017 |
Beebe-Dimmer JL, Yee C, Paskett E, Schwartz AG, Lane D, Palmer NRA, Bock CH, Nassir R, Simon MS. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative. Bmc Cancer. 17: 848. PMID 29237415 DOI: 10.1186/S12885-017-3873-5 |
0.408 |
|
| 2017 |
Thakur MK, Ruterbusch JJ, Schwartz AG, Gadgeel SM, Beebe-Dimmer JL, Wozniak AJ. Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology and End Results (SEER) Data. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28989038 DOI: 10.1016/j.jtho.2017.09.1964 |
0.311 |
|
| 2016 |
Giri VN, Beebe-Dimmer JL. Familial prostate cancer. Seminars in Oncology. 43: 560-565. PMID 27899188 DOI: 10.1053/j.seminoncol.2016.08.001 |
0.433 |
|
| 2016 |
Cooney KA, Beebe-Dimmer JL. HOXB13 mutations and prostate cancer risk Bju International. 118: 496-497. PMID 27625331 DOI: 10.1111/Bju.13477 |
0.328 |
|
| 2015 |
Beebe-Dimmer JL, Hathcock M, Yee C, Okoth LA, Ewing CM, Isaacs WB, Cooney KA, Thibodeau SN. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1366-72. PMID 26108461 DOI: 10.1158/1055-9965.Epi-15-0247 |
0.369 |
|
| 2015 |
Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer. 121: 1265-72. PMID 25754547 DOI: 10.1002/Cncr.29075 |
0.341 |
|
| 2015 |
Schottenfeld D, Beebe-Dimmer J. The cancer burden attributable to biologic agents. Annals of Epidemiology. 25: 183-7. PMID 25523895 DOI: 10.1016/J.Annepidem.2014.11.016 |
0.603 |
|
| 2015 |
Shore N, Concepcion R, Saltzstein D, Paivanas T, Beebe-Dimmer J, Ruterbusch J, Justiniano I, Mazure H, Nocon A, Soon J, Truong Q, Wissmueller S, Campbell D, Walsh B. PII-LBA3 GLYPICAN-1 AS A BIOMARKER FOR PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.JURO.2015.03.083 |
0.356 |
|
| 2014 |
Park SL, Caberto CP, Lin Y, Goodloe RJ, Dumitrescu L, Love SA, Matise TC, Hindorff LA, Fowke JH, Schumacher FR, Beebe-Dimmer J, Chen C, Hou L, Thomas F, Deelman E, et al. Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2568-78. PMID 25139936 DOI: 10.1158/1055-9965.Epi-14-0129 |
0.418 |
|
| 2014 |
Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA. Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study. Cancer. 120: 2735-41. PMID 24842808 DOI: 10.1002/Cncr.28769 |
0.414 |
|
| 2014 |
Neslund-Dudas C, Levin AM, Beebe-Dimmer JL, Bock CH, Nock NL, Rundle A, Jankowski M, Krajenta R, Dou QP, Mitra B, Tang D, Rebbeck TR, Rybicki BA. Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men. Cancer Causes & Control : Ccc. 25: 869-79. PMID 24801046 DOI: 10.1007/S10552-014-0387-1 |
0.337 |
|
| 2014 |
Neslund-Dudas C, Levin AM, Rundle A, Beebe-Dimmer J, Bock CH, Nock NL, Jankowski M, Datta I, Krajenta R, Dou QP, Mitra B, Tang D, Rybicki BA. Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer. The Prostate. 74: 637-46. PMID 24500903 DOI: 10.1002/Pros.22781 |
0.404 |
|
| 2014 |
Beebe-Dimmer JL, Isaacs WB, Zuhlke KA, Yee C, Walsh PC, Isaacs SD, Johnson AM, Ewing CE, Humphreys EB, Chowdhury WH, Montie JE, Cooney KA. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy. Bju International. 113: 830-5. PMID 24148311 DOI: 10.1111/Bju.12522 |
0.336 |
|
| 2014 |
Beebe-Dimmer J, Isaacs WB, Thibodeau SN, Yee C, Ewing C, Okoth L, Cooney KA. Association of the HOXB13 G84E mutation with increased risk for prostate cancer and other malignancies. Journal of Clinical Oncology. 32: 1558-1558. DOI: 10.1200/Jco.2014.32.15_Suppl.1558 |
0.399 |
|
| 2013 |
Schottenfeld D, Beebe-Dimmer JL, Buffler PA, Omenn GS. Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. Annual Review of Public Health. 34: 97-117. PMID 23514316 DOI: 10.1146/Annurev-Publhealth-031912-114350 |
0.61 |
|
| 2012 |
Beebe-Dimmer JL, Colt JS, Ruterbusch JJ, Keele GR, Purdue MP, Wacholder S, Graubard BI, Davis F, Chow WH, Schwartz KL. Body mass index and renal cell cancer: the influence of race and sex. Epidemiology (Cambridge, Mass.). 23: 821-8. PMID 23007040 DOI: 10.1097/Ede.0B013E31826B7Fe9 |
0.356 |
|
| 2012 |
Beebe-Dimmer JL, Iyer PT, Nriagu JO, Keele GR, Mehta S, Meliker JR, Lange EM, Schwartz AG, Zuhlke KA, Schottenfeld D, Cooney KA. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study. Environmental Health : a Global Access Science Source. 11: 43. PMID 22747749 DOI: 10.1186/1476-069X-11-43 |
0.587 |
|
| 2012 |
Bauer CM, Ishak MB, Johnson EK, Beebe-Dimmer JL, Cooney KA. Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer. Integrative Cancer Therapies. 11: 83-9. PMID 21821653 DOI: 10.1177/1534735411413262 |
0.361 |
|
| 2012 |
Jay AM, Bock CH, Dyson G, Beebe-Dimmer JL, Hou L, Howard BV, Prentice R, Simon MS. Abstract 07: The effect of genetic variants on the relationship between statins and breast cancer in the Women's Health Initiative Observational Study. Cancer Epidemiology Biomarkers & Prevention. 21: 07-7. DOI: 10.1158/1055-9965.Gwas-07 |
0.308 |
|
| 2011 |
Post JM, Beebe-Dimmer JL, Morgenstern H, Neslund-Dudas C, Bock CH, Nock N, Rundle A, Jankowski M, Rybicki BA. The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy. Prostate Cancer. 2011: 245642. PMID 22096652 DOI: 10.1155/2011/245642 |
0.327 |
|
| 2011 |
Beebe-Dimmer J, Shahinian V. Tackling overtreatment of prostate cancer: the role of comorbidity. Cancer. 117: 4576-8. PMID 21480202 DOI: 10.1002/cncr.26106 |
0.363 |
|
| 2011 |
Beebe-Dimmer J, Morgenstern H, Cetin K, Yee C, Bartoces M, Shahinian V, Fryzek J, Acquavella J, Schwartz KL. Androgen deprivation therapy and cataract incidence among elderly prostate cancer patients in the United States. Annals of Epidemiology. 21: 156-63. PMID 21109456 DOI: 10.1016/J.Annepidem.2010.10.003 |
0.37 |
|
| 2011 |
Elson JK, Beebe-Dimmer JL, Morgenstern H, Chilkuri M, Blanchard J, Lentsch AB. The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men. Journal of Immigrant and Minority Health / Center For Minority Public Health. 13: 36-41. PMID 20596779 DOI: 10.1007/S10903-010-9330-Z |
0.348 |
|
| 2010 |
Cetin K, Beebe-Dimmer JL, Fryzek JP, Markus R, Carducci MA. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology. 75: 1396-404. PMID 19969335 DOI: 10.1016/j.urology.2009.07.1360 |
0.364 |
|
| 2009 |
Nock NL, Bock C, Neslund-Dudas C, Beebe-Dimmer J, Rundle A, Tang D, Jankowski M, Rybicki BA. Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Cancer Causes & Control : Ccc. 20: 1915-26. PMID 19568698 DOI: 10.1007/S10552-009-9385-0 |
0.377 |
|
| 2009 |
Beebe-Dimmer JL, Nock NL, Neslund-Dudas C, Rundle A, Bock CH, Tang D, Jankowski M, Rybicki BA. Racial differences in risk of prostate cancer associated with metabolic syndrome. Urology. 74: 185-90. PMID 19428088 DOI: 10.1016/J.Urology.2009.03.013 |
0.324 |
|
| 2009 |
Schottenfeld D, Beebe-Dimmer JL, Vigneau FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Annals of Epidemiology. 19: 58-69. PMID 19064190 DOI: 10.1016/J.Annepidem.2008.10.004 |
0.539 |
|
| 2009 |
Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, Walters S, Cooney KA. Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23. The Prostate. 69: 385-91. PMID 19035517 DOI: 10.1002/Pros.20891 |
0.388 |
|
| 2008 |
Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, Johnson GR, Cooney KA, Douglas JA. Chromosome 8q24 markers: risk of early-onset and familial prostate cancer. International Journal of Cancer. Journal International Du Cancer. 122: 2876-9. PMID 18360876 DOI: 10.1002/Ijc.23471 |
0.366 |
|
| 2007 |
Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG, Hanks G, Godwin AK, Chen DY, Gordon R, Cescon T, Raysor S, Watkins-Bruner D. Prostate cancer risk assessment program: a 10-year update of cancer detection. The Journal of Urology. 178: 1920-4; discussion 1. PMID 17868726 DOI: 10.1016/J.Juro.2007.07.010 |
0.388 |
|
| 2007 |
Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA. Features of the metabolic syndrome and prostate cancer in African-American men. Cancer. 109: 875-81. PMID 17265528 DOI: 10.1002/Cncr.22461 |
0.403 |
|
| 2006 |
Schottenfeld D, Beebe-Dimmer J. Alleviating the burden of cancer: a perspective on advances, challenges, and future directions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2049-55. PMID 17119027 DOI: 10.1158/1055-9965.Epi-06-0603 |
0.645 |
|
| 2006 |
Beebe-Dimmer JL, Drake EA, Dunn RL, Bock CH, Montie JE, Cooney KA. Association between family history of prostate and breast cancer among African-American men with prostate cancer. Urology. 68: 1072-6. PMID 17095075 DOI: 10.1016/J.Urology.2006.06.028 |
0.363 |
|
| 2006 |
Wang X, Wang F, Taniguchi K, Seelan RS, Wang L, Zarfas KE, McDonnell SK, Qian C, Pan K, Lu Y, Shridhar V, Couch FJ, Tindall DJ, Beebe-Dimmer JL, Cooney KA, et al. Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk. Cancer Research. 66: 10302-7. PMID 17079449 DOI: 10.1158/0008-5472.Can-06-0638 |
0.338 |
|
| 2006 |
Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, ... ... Beebe-Dimmer JL, et al. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Human Genetics. 120: 471-85. PMID 16932970 DOI: 10.1007/s00439-006-0219-9 |
0.343 |
|
| 2006 |
Schottenfeld D, Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. Ca: a Cancer Journal For Clinicians. 56: 69-83. PMID 16514135 DOI: 10.3322/Canjclin.56.2.69 |
0.565 |
|
| 2005 |
Douglas JA, Zuhlke KA, Beebe-Dimmer J, Levin AM, Gruber SB, Wood DP, Cooney KA. Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2035-9. PMID 16103457 DOI: 10.1158/1055-9965.Epi-05-0170 |
0.462 |
|
| 2005 |
Claeys GB, Sarma AV, Dunn RL, Zuhlke KA, Beebe-Dimmer J, Montie JE, Wojno KJ, Schottenfeld D, Cooney KA. INSPstI polymorphism and prostate cancer in African-American men. The Prostate. 65: 83-7. PMID 15880482 DOI: 10.1002/Pros.20271 |
0.593 |
|
| 2005 |
Schottenfeld D, Beebe-Dimmer JL. Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions. Annual Review of Public Health. 26: 37-60. PMID 15760280 DOI: 10.1146/Annurev.Publhealth.26.021304.144402 |
0.636 |
|
| 2005 |
Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Annals of Epidemiology. 15: 175-84. PMID 15723761 DOI: 10.1016/J.Annepidem.2004.05.015 |
0.516 |
|
| 2004 |
Zuhlke KA, Madeoy JJ, Beebe-Dimmer J, White KA, Griffin A, Lange EM, Gruber SB, Ostrander EA, Cooney KA. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5975-80. PMID 15447980 DOI: 10.1158/1078-0432.Ccr-04-0554 |
0.412 |
|
| 2004 |
Giri VN, Cassidy AE, Beebe-Dimmer J, Ellis L, Smith DC, Bock CH, Cooney KA. Association between Agent Orange and prostate cancer: a pilot case-control study. Urology. 63: 757-60; discussion 7. PMID 15072895 DOI: 10.1016/J.Urology.2003.11.044 |
0.525 |
|
| 2004 |
Beebe-Dimmer J, Lynch JW, Turrell G, Lustgarten S, Raghunathan T, Kaplan GA. Childhood and Adult Socioeconomic Conditions and 31-Year Mortality Risk in Women American Journal of Epidemiology. 159: 481-490. PMID 14977644 DOI: 10.1093/Aje/Kwh057 |
0.301 |
|
| 2004 |
Beebe-Dimmer JL, Wood DP, Gruber SB, Douglas JA, Bonner JD, Mohai C, Zuhlke KA, Shepherd C, Cooney KA. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study. Urology. 63: 282-7. PMID 14972472 DOI: 10.1016/J.Urology.2003.09.036 |
0.306 |
|
| 2003 |
Mayes MD, Lacey JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population Arthritis and Rheumatism. 48: 2246-2255. PMID 12905479 DOI: 10.1002/Art.11073 |
0.545 |
|
| Show low-probability matches. |